The Hsp60 folding machinery is crucial for manganese superoxide dismutase folding and function

Free Radical Research

Volumn 48, Issue 2, 2014, Pages 168-179

  Magnoni, R ^a   Palmfeldt, J ^a   Hansen, J ^b   Christensen, J H ^c   Corydon, T J ^c   Bross, P ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Hsp60; MnSOD; Neurodegeneration; Oxidative stress; SPG13

Indexed keywords

CHAPERONIN 60; MANGANESE SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; SCAVENGING SYSTEM;

ANIMALS; CEREBRAL CORTEX; CHAPERONIN 60; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; OXIDATIVE STRESS; PROTEIN FOLDING; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TRANSCRIPTION, GENETIC;

EID: 84890015010     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2013.858147     Document Type: Article

References (44)

1. TB, Austad, SN. Why do we age? Nature 2000; 408: 233-238.
2. Moreira PI, Santos MS, Oliveira CR. Alzheimer's disease: A lesson from mitochondrial dysfunction. Antioxid Redox Signal 2007; 9: 1621-1630.
3. Schapira AH. Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol 2008; 7: 97-109.
4. Ferrante RJ, Browne SE, Shinobu LA, Bowling AC, Baik MJ, MacGarvey U, et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 1997; 69: 2064-2074.
5. Shaw PJ, Ince PG, Falkous G, Mantle D. Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann Neurol 1995; 38: 691-695.
6. Maltecca F, Magnoni R, Cerri F, Cox GA, Quattrini A, Casari G. Haploinsufficiency of AFG3L2, the gene responsible for spinocerebellar ataxia type 28, causes mitochondriamediated Purkinje cell dark degeneration. J Neurosci 2009; 29: 9244-9254.
7. Hansen JJ, Durr A, Cournu-Rebeix I, Georgopoulos C, Ang D, Nielsen MN, et al. Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. Am J Hum Genet 2002; 70: 1328-1332.
8. Hansen J, Svenstrup K, Ang D, Nielsen MN, Christensen JH, Gregersen N, et al. A novel mutation in the HSPD1 gene in a patient with hereditary spastic paraplegia. J Neurol 2007; 254: 897-900.
9. Magen D, Georgopoulos C, Bross P, Ang D, Segev Y, Goldsher D, et al. Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy. Am J Hum Genet 2008; 83: 30-42.
10. Hansen JJ, D ü rr A, Cournu-Rebeix I, Georgopoulos C, Ang D, Nielsen MN, et al. Hereditary Spastic Paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial Chaperonin Hsp60. Am J Hum Genet 2002; 70: 1328-1332.
11. McDermott CJ, Grierson AJ, Wood JD, Bingley M, Wharton SB, Bushby KM, Shaw PJ. Hereditary spastic paraparesis: Disrupted intracellular transport associated with spastin mutation. Ann Neurol 2003; 54: 748-759.
12. Cheng MY, Hartl FU, Martin J, Pollock RA, Kalousek F, Neupert W, et al. Mitochondrial heat-shock protein hsp60 is essential for assembly of proteins imported into yeast mitochondria. Nature 1989; 337: 620-625.
13. Christensen JH, Nielsen MN, Hansen J, Fuchtbauer A, Fuchtbauer EM, West M, et al. Inactivation of the hereditary spastic paraplegia-Associated Hspd1 gene encoding the Hsp60 chaperone results in early embryonic lethality in mice. Cell Stress Chaperones 2010; 15: 851-863.
14. Yebenes H, Mesa P, Munoz IG, Montoya G, Valpuesta JM. Chaperonins: Two rings for folding. Trends Biochem Sci 2011; 36: 424-432.
15. Horwich AL, Fenton WA, Chapman E, Farr GW. Two families of chaperonin: Physiology and mechanism. Annu Rev Cell Dev Biol 2007; 23: 115-145.
16. Bross P, Magnoni R, Bie AS. Molecular chaperone disorders: Defective Hsp60 in neurodegeneration. Curr Top Med Chem 2013; 12: 2491-2503.
17. Karbowski M, Neutzner A. Neurodegeneration as a consequence of failed mitochondrial maintenance. Acta Neuropathol 2012; 123: 157-171.
18. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 2009; 417: 1-13.
19. Brand MD. The sites and topology of mitochondrial superoxide production. Exp Gerontol 2010; 45: 466-472.
20. Borgstahl GE, Parge HE, Hickey MJ, Beyer WF Jr, Hallewell RA, Tainer JA. The structure of human mitochondrial manganese superoxide dismutase reveals a novel tetrameric interface of two 4-helix bundles. Cell 1992; 71: 107-118.
21. Tahara EB, Navarete FD, Kowaltowski AJ. Tissue-, substrate-, and site-specific characteristics of mitochondrial reactive oxygen species generation. Free Radic Biol Med 2009; 46: 1283-1297.
22. Baker BM, Haynes CM. Mitochondrial protein quality control during biogenesis and aging. Trends Biochem Sci 2011; 36: 254-261.
23. Gregersen N, Bross P, Vang S, Christensen JH. Protein misfolding and human disease. Annu Rev Genomics Hum Genet 2006; 7: 103-124.
24. Magnoni R, Palmfeldt J, Christensen JH, Sand M, Maltecca F, Corydon TJ, et al. Late onset motoneuron disorder caused by mitochondrial Hsp60 chaperone deficiency in mice. Neurobiol Dis 2013; 54: 12-23.
25. Palmfeldt J, Vang S, Stenbroen V, Pavlou E, Baycheva M, Buchal G, et al. Proteomics reveals that redox regulation is disrupted in patients with ethylmalonic encephalopathy. J Proteome Res 2011; 10: 2389-2396.
26. Weydert CJ, Cullen JJ. Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nat Protoc 2010; 5: 51-66.
27. Hansen J, Corydon TJ, Palmfeldt J, Durr A, Fontaine B, Nielsen MN, et al. Decreased expression of the mitochondrial matrix proteases Lon and ClpP in cells from a patient with hereditary spastic paraplegia (SPG13). Neuroscience 2008; 153: 474-482.
28. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996; 6: 986-994.
29. Winer J, Jung CK, Shackel I, Williams PM. Development and validation of real-Time quantitative reverse transcriptasepolymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 1999; 270: 41-49.
30. Pedersen CB, Kolvraa S, Kolvraa A, Stenbroen V, Kjeldsen M, Ensenauer R, et al. The ACADS gene variation spectrum in 114 patients with short-chain acyl-CoA dehydrogenase (SCAD) deficiency is dominated by missense variations leading to protein misfolding at the cellular level. Hum Genet 2008; 124: 43-56.
31. Requena JR, Levine RL, Stadtman ER. Recent advances in the analysis of oxidized proteins. Amino Acids 2003; 25: 221-226.
32. Nystrom T. Role of oxidative carbonylation in protein quality control and senescence. EMBO J 2005; 24: 1311-1317.
33. Sies H. Oxidative stress: Oxidants and antioxidants. Exp Physiol 1997; 82: 291-295.
34. Lebovitz RM, Zhang H, Vogel H, Cartwright J Jr, Dionne L, Lu N, et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci USA 1996; 93: 9782-9787.
35. Strassburger M, Bloch W, Sulyok S, Schuller J, Keist AF, Schmidt A, et al. Heterozygous deficiency of manganese superoxide dismutase results in severe lipid peroxidation and spontaneous apoptosis in murine myocardium in vivo. Free Radic Biol Med 2005; 38: 1458-1470.
36. Van RH, Ikeno Y, Hamilton M, Pahlavani M, Wolf N, Thorpe SR, et al. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics 2003; 16: 29-37.
37. Stack EC, Matson WR, Ferrante RJ Evidence of oxidant damage in Huntington's disease: Translational strategies using antioxidants. Ann N Y Acad Sci 2008; 1147: 79-92.
38. Finsterer J. Parkinson's syndrome and Parkinson's disease in mitochondrial disorders. Mov Disord 2011; 26: 784-791.
39. Ferreirinha F, Quattrini A, Pirozzi M, Valsecchi V, Dina G, Broccoli V, et al. Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J Clin Invest 2004; 113: 231-242.
40. Mojsilovic-Petrovic J, Nedelsky N, Boccitto M, Mano I, Georgiades SN, Zhou W, et al. FOXO3a is broadly neuroprotective in vitro and in vivo against insults implicated in motor neuron diseases. J Neurosci 2009; 29: 8236-8247.
41. Yamakura F, Kawasaki H. Post-Translational modifications of superoxide dismutase. Biochim Biophys Acta 2010; 1804: 318-325.
42. Aoyama K, Matsubara K, Fujikawa Y, Nagahiro Y, Shimizu K, Umegae N, et al. Nitration of manganese superoxide dismutase in cerebrospinal fl uids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases. Ann Neurol 2000; 47: 524-527.
43. Anantharaman M, Tangpong J, Keller JN, Murphy MP, Markesbery WR, Kiningham KK, St Clair DK. Beta-Amyloid mediated nitration of manganese superoxide dismutase: Implication for oxidative stress in a APPNLH/NLH X PS-1P264L/ P264L double knock-in mouse model of Alzheimer's disease. Am J Pathol 2006; 168: 1608-1618.
44. Sompol P, Ittarat W, Tangpong J, Chen Y, Doubinskaia I, Batinic-Haberle I, et al. A neuronal model of Alzheimer's disease: An insight into the mechanisms of oxidative stress-mediated mitochondrial injury. Neuroscience 2008; 153: 120-130.